Clinical Trial Update: Safety and Feasibility of Intranasal Insulin in Patients With Spinal Cord Injury [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety and feasibility of intranasal insulin in individuals with spinal cord injury; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Intranasal insulin (insulin)

Snippet

Sponsor: HealthPartners Institute | Conditions: Spinal Cord Injury | Phase 1 | Status: RECRUITING